Follistim Aq Injection, Solution
Product Images NDC 78206-129

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Follistim Aq (NDC 78206-129). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Organon Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Follistim Aq Cartridge 01)

A line graph comparing follicle-stimulating hormone (FSH) concentration in IU/L over assessment weeks for 150 IU and 225 IU dosages. The graph shows two data series with error bars, indicating the FSH levels for each dosage across multiple time points up to week 65.*

FDA Label Image

Figure 1 (Follistim Aq Cartridge 02)

An instructional diagram displaying the components of a Follistim AQ injection pen, a subcutaneous injection solution containing follitropin. The illustration labels parts including the protective cap with pocket clip, cartridge holder, black rod, dosage window and dosage scale, injection button, body, and dosage knob.*

FDA Label Image

Figure 2 (Follistim Aq Cartridge 03)

An instructional diagram showing parts of a syringe, including a rubber inlay, a metal-rimmed cap at the top, and a rubber piston inside the barrel. The image highlights specific components of a syringe assembly.*

FDA Label Image

Figure 3 (Follistim Aq Cartridge 04)

An instructional diagram showing components of a BD Micro-Fine Pen Needle Unit. It labels the outer needle shield, inner needle shield, protective paper seal, BD Micro-Fine pen needle, and clear threaded hub.*

FDA Label Image

Figure 4 (Follistim Aq Cartridge 05)

An instructional illustration showing a person holding a syringe and removing its cap by pulling upward, indicated by a black arrow. The image demonstrates the proper step for preparing an injection, likely related to the use of Follistim AQ injection.*

FDA Label Image

Figure 5 (Follistim Aq Cartridge 06)

An instructional illustration showing a person holding a syringe and a vial, demonstrating the process of drawing medication from the vial into the syringe, likely related to injection preparation.*

FDA Label Image

Figure 6 (Follistim Aq Cartridge 07)

An instructional illustration showing a hand holding and preparing an injection device, likely a syringe or pen, with an arrow indicating the direction for attaching or inserting a component. The image is related to the use of Follistim AQ injection, solution for subcutaneous administration.*

FDA Label Image

Triangle (Follistim Aq Cartridge 08)

Packaging label for Follistim AQ injection, solution, containing follitropin. Available in 900 iU/1.08 mL strength as shown. The label includes a lot number, expiration date, and level indicator window for the cartridge inside the carton. The labeler is Organon LLC.*

FDA Label Image

Rectangle (Follistim Aq Cartridge 09)

Follistim AQ 300 IU/0.36 mL injection solution, subcutaneous use, by Organon LLC. The vial contains 300 international units of follitropin in a clear liquid solution, with labeling indicating the product name, strength, and route of administration. The vial has a white cap and additional text details on the label.*

FDA Label Image

Figure 7 (Follistim Aq Cartridge 10)

An instructional illustration showing a hand holding and inserting a plunger into a syringe or injection device. The image appears to demonstrate the technique of preparing or actuating an injection device, possibly related to the administration of Follistim AQ injection solution.*

FDA Label Image

Figure 8 (Follistim Aq Cartridge 11)

An instructional illustration showing hands holding a syringe and needle, demonstrating how to attach or prepare the syringe for injection, likely related to subcutaneous administration of Follistim AQ (follitropin) injection solution.*

FDA Label Image

Figure 9 (Follistim Aq Cartridge 12)

Black and white instructional illustration showing a person holding a vial and a screw-top cap, preparing to attach or detach the cap from the vial. The image likely demonstrates a step in the handling or preparation of the Follistim AQ injection solution.*

FDA Label Image

Figure 10 (Follistim Aq Cartridge 13)

An instructional illustration showing a hand holding a syringe-like device, rotating the upper part, indicating the motion needed to prepare or adjust the injection device for subcutaneous administration of Follistim AQ.*

FDA Label Image

Figure 11 (Follistim Aq Cartridge 14)

An anatomical illustration showing the front lower abdomen area with a marked injection site. The image likely indicates the subcutaneous injection location for Follistim AQ, a follitropin injection solution used in human prescription drugs.*

FDA Label Image

Figure 12 (Follistim Aq Cartridge 15)

FDA Label Image

Figure 13 (Follistim Aq Cartridge 16)

An instructional illustration showing two hands manipulating a syringe, with one hand holding the syringe barrel and the other hand pulling the plunger upward, indicated by an arrow pointing up. The image demonstrates the motion of drawing medication into the syringe, associated with subcutaneous injection preparation for Follistim AQ (follitropin) injection solution.*

FDA Label Image

Figure 14 (Follistim Aq Cartridge 17)

An instructional illustration showing a hand holding a prefilled syringe for Follistim AQ injection solution, demonstrating the removal of the needle cap by pulling it straight off. The diagram supports proper preparation for subcutaneous administration of the medication.*

FDA Label Image

Figure 15 (Follistim Aq Cartridge 18)

An illustration showing a syringe presumably used for subcutaneous injection. The image depicts the syringe held in a hand, emphasizing the injection technique or preparation process, likely related to Follistim AQ injection solution.*

FDA Label Image

Figure 16 (Follistim Aq Cartridge 19)

An instructional line drawing showing a person holding a syringe or injection device with both hands. The image likely demonstrates proper handling or preparation technique for an injection, consistent with the subcutaneous administration route of Follistim AQ (follitropin) injection solution.*

FDA Label Image

Figure 17 (Follistim Aq Cartridge 20)

Two black and white instructional illustrations showing steps for using an injection device. The top image depicts twisting or unlocking a part of the device as indicated by a curved arrow. The bottom image shows inserting a cartridge or component into the device with a downward arrow. Both images focus on hand positioning and device handling.*

FDA Label Image

Figure 18 (Follistim Aq Cartridge 21)

An instructional line drawing illustrating a hand administering a subcutaneous injection using a syringe. The image depicts the syringe inserting into the skin, demonstrating correct injection technique for subcutaneous delivery.*

FDA Label Image

Figure 19 (Follistim Aq Cartridge 22)

An instructional illustration showing a hand holding a syringe. The image emphasizes removing or pulling down a cap or cover from the syringe, indicated by a downward-pointing arrow. The image is likely related to preparing the Follistim AQ injection.*

FDA Label Image

Figure 20 (Follistim Aq Cartridge 23)

An instructional illustration showing hands preparing an injection using a syringe and vial. The image depicts the process of drawing medication from the vial into the syringe before administration.*

FDA Label Image

Figure 21 (Follistim Aq Cartridge 24)

An instructional illustration showing two hands handling a syringe and vial. One hand holds the vial while the other is drawing solution into the syringe, indicating preparation for subcutaneous injection.*

FDA Label Image

Figure 22 (Follistim Aq Cartridge 25)

An instructional diagram showing hands handling a syringe with a vial. The image depicts drawing medication from the vial into the syringe, demonstrating preparation for injection.*

FDA Label Image

Figure 23 (Follistim Aq Cartridge 26)

A data table showing a dosing schedule for Follistim AQ injection solution. Columns list Day, Date (month/day/year format), Dose Prescribed in units, and Cartridge Content Available and Remaining in iU. The table illustrates the decrement of cartridge content available and remaining over four days with a daily dose of 150 iU.*

FDA Label Image

Principal Display Panel (300 IU Kit Carton)

Follistim AQ Cartridge 300 IU (follitropin beta) injection label for subcutaneous use. The label indicates it is for use only with the Follistim Pen, containing a sterile prefilled cartridge with 0.36 mL of medication and 5 BD Micro-Fine Pen Needles. Labeler is Organon LLC. The box includes storage instructions and a note to dispense with full prescribing information.*

FDA Label Image

Principal Display Panel (600 IU Kit Carton)

Packaging label for Follistim AQ Cartridge 600 IU (follitropin beta) injection, solution for subcutaneous use. The label indicates it contains 1 sterile prefilled cartridge with 0.72 mL and 7 BD Micro-Fine Pen Needles. Manufactured by Organon LLC, the label emphasizes use only with Follistim Pen and displays dosage form, strength, NDC 78206-130-01, and storage and contact information.*

FDA Label Image

Principal Display Panel (900 IU Kit Carton)

Box packaging label for Follistim AQ Cartridge 900 IU (follitropin beta) injection, a subcutaneous solution by Organon LLC. The label indicates a single prefilled cartridge with 1.08 mL of medication and includes 10 BD Micro-Fine pen needles. It states product use is for single-patient, subcutaneous administration and requires dispensing with full prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.